UP

US approves new drug to treat Alzheimer's disease

Home page Science
12 Punto 14 Punto 16 Punto 18 Punto
US approves new drug to treat Alzheimer's disease

The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease.

Axar.az reports the FDA approval of the drug, Leqembi, also known as lecanemab, comes just days after the regulatory agency was harshly criticised in a congressional report for its green-lighting of another Alzheimer's drug, Aduhelm.

And it was granted despite trial results showing the monoclonal antibody treatment carries risks of brain swelling and bleeding.

Both drugs were approved through an accelerated process that allows the FDA to fast-track approval of drugs for serious conditions where there is an unmet medical need.

Date
2023.01.07 / 11:38
Author
Axar.az
See also

Putin arrived in China for APEC summit - Video

Azerbaijan U-19 beat Faroe Islands 2-0

19 killed in An-12 military plane crash in Russia - Video

IRGC warns Bahrain over alleged actions against Iran

Azerbaijan included in US mine clearance funding plan

Rutte backs Ukraine’s strikes on Russian logistics hubs

France sees sharp fall in turnout at public sector protests

Russia warns France over possible troop deployment in Ukraine

Biden calls Ukraine's 2008 NATO promise 'premature'

UK to supply Ukraine with over 1,000 air defence missiles

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla